Langerhans cell histiocytosis (LCH), formerly known under a variety of different names such as histiocytosis X, eosinophilic granuloma, Hand-Schüller-Christian disease or Letterer-Siwe disease, is a rare disease of the family of histiocytosis characterized by the accumulation of histiocytic cells in various tissues. The discovery of Birbeck granules in the histiocytes of this disease and the expression of similar antigens has led to the name Langerhans cell histiocytosis. However newer findings show that LCH origins from dendritic myeloid progenitor cells rather than Langerhans cells of the skin [
1]. LCH has a relatively higher incidence in children under the age of 15 years (5:1′000’000) but can also occur more rarely in adults (around 1:1′000’000). The etiology of the disease is still unknown, and there has been considerable debate whether LCH represents an inflammatory or a neoplastic disease. The discovery of recurrent mutations in the mitogen activated protein kinase (MAPK) pathway (i.e.
BRAF and
MAP2K1 mutations) indicates that it is a neoplastic disease [
2,
3]. Recently the Histiocyte Society has published a revised classification of histiocytoses in which LCH is sub classified according to site of manifestation and organ involvement: single system LCH, lung LCH and multi system LCH with or without risk organ involvement (risk organs: liver, spleen, bone marrow) [
4]. Single system LCH affecting the skin or bone are the most frequent clinical manifestations, other less frequent sites of involvement include: pituitary gland, liver, spleen, bone marrow, lungs, lymph nodes and the central nervous system, although every organ can be affected. Lung LCH is considered separately in the classification, as it is very frequently associated with cigarette smoking, occurs predominantly in adults and is considered a form of interstitial lung disease [
5]. A small, but not neglectable number of patients with multisystem, cranial or facial bone osteolytic lesions may develop diabetes insipidus, caused by lesions of the neurohypophysis or the supraoptic and paraventricular nuclei, sometimes representing the initial manifestation of the disease [
6]. The clinical symptoms of LCH are usually seen as a secondary consequence of organ dysfunction. Skin lesions may present as papules or eczematous lesions, isolated or generealised [
5]. Patients with bone LCH most often present localized pain and swelling of the affected area, sometimes with concurrent fever and the most commonly affected bones are the skull and the jawbone. In the oral region reported symptoms are gingivitis, periodontitis, tooth rotation or loss and malocclusion [
7].
Possible differential diagnoses of LCH are other cutaneous histiocytoses such as xanthogranulomas, normolipemic granulomas, histiocytomas or haemophagocytic lymphohistiocytosis and should be considered [
8]. In the present case the clinical presentation is difficult to be distinguished from medication related osteonecrosis of the jaw (MRONJ) or possible neoplastic lesions. Definite diagnosis will be achieved by the histopathological examination [
9].
This case report informs the readership on methods of clinical and radiographic examination as well as treatment of this rare disease on the basis of this case. The importance of a thorough dental examination has also been underlined in a case of oral Multisystem LCH [
10]. Although LCH is rare, it should be considered as a potential diagnosis.